Contents
pdf Download PDF pdf Download XML
92 Views
38 Downloads
Share this article
Research Article | Volume 11 Issue 3 (None, 2017) | Pages 87 - 88
Photoletter to the editor: Topical 0.5% brimonidine gel to camouflage redness of immature scars
 ,
 ,
 ,
 ,
 ,
Under a Creative Commons license
Open Access
PMID : PMC4619167
Received
April 8, 2015
Published
Sept. 30, 2015
Abstract

Cutaneous scars develop as a result of a defective wound healing process. Scars are commonly visible as erythematous, sometimes disfiguring lesions which might be stigmatizing for the affected patient. Only a few therapies to improve the appearance of scars are available. Recently, brimonidine — a selective α2-receptor-agonist which causes vasoconstriction of small cutaneous vessels — was approved for the treatment of erythemato-telangiectatic rosacea. Topical brimonidine might also be helpful to improve redness of immature scars. Here we report on the effect of brimonidine 0.5% gel on a flat, erythematous scar in a 25-year-old female patient. Whitening of the scar could be observed immediately after application of brimonidine 0.5% gel and a good clinical result was observed within one hour. This effect lasted for up to three hours. We conclude that brimonidine 0.5% gel is a suitable topical therapy to reduce erythema in visible cutaneous scars.

Keywords
Recommended Articles
Case Report
Concurrent Lepra Reactions; Type 1 and Type 2 in a young male patient with borderline leprosy: Clinical and Histopathological correlation
...
Published: 02/09/2025
Original Article
Comparative Evaluation of Intralesional Corticosteroid Injection and Surgical Excision in Hypertrophic Scar Treatment
...
Published: 04/06/2022
Research Article
Efficacy of supra bioavailable itraconazole and conventional itraconazole at different dosing regimens in glabrous tinea infection
Published: 02/02/2024
Research Article
Surgical suturing-induced melanocytic nevi. A new type of eruptive melanocytic nevi?
...
Published: 30/11/2016
© Copyright Spejalisci Dermatolodzy